Flatley Discovery Lab LLC   Report issue

Foundation Phase 1 Phase 2
Founded: Boston MA United States (2009)

Organization Overview

First Clinical Trial
2015
NCT02359357
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Flatley Discovery Lab | Flatley Discovery Lab LLC